関連する実験動画
Updated: Aug 1, 2026

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
まとめ
この研究では,エフェドリン硫酸とセオフィリンを併用することは,喘息の子供にとって安全であることが判明しました. この薬剤の組み合わせは,8週間にわたって有毒性または耐性の発達を示せず,効果的な支支支管管拡張を提供しました.
科学分野:
- 小児肺病学について
- 臨床薬理学 臨床薬理学とは
- アズマ管理 アズマ管理
背景:
- 喘息は,子供に影響を与える慢性呼吸器疾患であり, bronchodilatorsでしばしば管理されます.
- テオフィリンは,一般的な喘息薬ですが,その有効性と安全性は向上することができます.
- エフェドリン硫酸は,セオフィリンと組み合わせた場合,潜在的にシネジスティックな効果を持つ支支管管拡張剤です.
研究 の 目的:
- 小児性喘息患者におけるエフェドリン硫酸とテオフィリンを併用した療法の有効性と安全性を評価する.
- 8週間の間にわたってこの組み合わせに対する耐性の発達を評価する.
- 薬剤の組み合わせの支氣管拡張剤反応と潜在的な毒性を決定するために.
主な方法:
- 7歳から13歳までの16人の喘息児を対象としたダブルブラインド研究.
- 13人の参加者は,継続的なセオフィリン療法を受けた.
- 投与後6時間の間,肺機能検査は1時間ごとに実施され,毒性は観察と患者の質問を通じて監視された.
主要な成果:
- エフェドリン硫酸塩とセオフィリンを併用した結果,有意な毒性や有害な副作用は報告されていません.
- 肺機能データは,効果が低下することなく, bronchodilator への持続的な反応を示した.
- 1週と8週間のデータを分析したところ,耐性発達の証拠は見つかりませんでした.
結論:
- エフェドリン硫酸は,小児性喘息患者において,セオフィリンの治療用量と共に安全に投与することができます.
- この組み合わせは,漸進的な耐性または毒性を誘導することなく,効果的な支支支管管拡張を提供します.
- このレジメンは,小児性喘息の管理に安全で効果的な選択肢です.
関連する概念動画
Adrenergic Agonists: Mixed-Action Agents
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

